Chen S, Zhang C, Chen D, Dong L, Chang T, Tang Z
Front Immunol. 2023; 14:1200289.
PMID: 37483597
PMC: 10358730.
DOI: 10.3389/fimmu.2023.1200289.
Adimulam T, Arumugam T, Gokul A, Ramsuran V
Int J Mol Sci. 2023; 24(10).
PMID: 37240057
PMC: 10218380.
DOI: 10.3390/ijms24108711.
Cheng S, Wang P, Chang C, Wang H, Wang C, Chiu K
Drug Des Devel Ther. 2023; 17:87-92.
PMID: 36698540
PMC: 9869894.
DOI: 10.2147/DDDT.S392708.
Ntounis T, Prokopakis I, Koutras A, Fasoulakis Z, Pittokopitou S, Valsamaki A
J Clin Med. 2022; 11(22).
PMID: 36431122
PMC: 9695358.
DOI: 10.3390/jcm11226645.
Abadi B, Aarabi Jeshvaghani A, Fathalipour H, Dehghan L, Rahimi Sirjani K, Forootanfar H
Iran J Med Sci. 2022; 47(6):517-532.
PMID: 36380976
PMC: 9652495.
DOI: 10.30476/IJMS.2021.92662.2396.
Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directions.
Vitiello A, Zovi A, Trama U, Ferrara F
Herz. 2022; 48(5):372-375.
PMID: 36331568
PMC: 9638345.
DOI: 10.1007/s00059-022-05142-6.
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study.
Shokri F, Rezapoor S, Najafi M, Asadi M, Alavije M, Abolhassani M
Vacunas. 2022; 24(2):141-149.
PMID: 36211984
PMC: 9531663.
DOI: 10.1016/j.vacun.2022.09.077.
Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view.
Ferrara F, Zovi A, Trama U, Vitiello A
Inflammopharmacology. 2022; 30(5):1927-1931.
PMID: 35980509
PMC: 9386652.
DOI: 10.1007/s10787-022-01055-2.
Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection.
Vitiello A, Ferrara F
Int J Mol Sci. 2022; 23(12).
PMID: 35743089
PMC: 9224264.
DOI: 10.3390/ijms23126644.
Pregnancy and COVID-19, focus on vaccine and pharmacological treatment.
Vitiello A, Ferrara F, Zovi A, Trama U, Boccellino M
J Reprod Immunol. 2022; 151:103630.
PMID: 35483212
PMC: 9023094.
DOI: 10.1016/j.jri.2022.103630.
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis.
Wen W, Chen C, Tang J, Wang C, Zhou M, Cheng Y
Ann Med. 2022; 54(1):516-523.
PMID: 35118917
PMC: 8820829.
DOI: 10.1080/07853890.2022.2034936.
Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients.
Vitiello A, Ferrara F
Curr Res Pharmacol Drug Discov. 2021; 2:100056.
PMID: 34870154
PMC: 8444447.
DOI: 10.1016/j.crphar.2021.100056.
Commentary of the mRNA vaccines COVID-19.
Vitiello A, Ferrara F
Asian J Pharm Sci. 2021; 16(5):531-532.
PMID: 34849160
PMC: 8609436.
DOI: 10.1016/j.ajps.2021.05.004.
Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection.
Vitiello A, Ferrara F
Mol Biol Rep. 2021; 49(1):827-831.
PMID: 34839450
PMC: 8627294.
DOI: 10.1007/s11033-021-06888-8.
Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment.
Vitiello A, Ferrara F
Egypt Heart J. 2021; 73(1):103.
PMID: 34792677
PMC: 8600338.
DOI: 10.1186/s43044-021-00228-8.
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in healthy individuals: protocol for a systematic review and meta-analysis.
Li M, Yang X, Jiang L, Yang D
BMJ Open. 2021; 11(11):e056106.
PMID: 34740936
PMC: 8573293.
DOI: 10.1136/bmjopen-2021-056106.
A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy?.
Vitiello A, Ferrara F
Immunol Res. 2021; 70(1):129-133.
PMID: 34739696
PMC: 8570229.
DOI: 10.1007/s12026-021-09244-x.
An Overview on the Potential Roles of EGCG in the Treatment of COVID-19 Infection.
Bimonte S, Forte C, Cuomo M, Esposito G, Cascella M, Cuomo A
Drug Des Devel Ther. 2021; 15:4447-4454.
PMID: 34737551
PMC: 8560077.
DOI: 10.2147/DDDT.S314666.
SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies.
Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F
Int Immunopharmacol. 2021; 101(Pt A):108232.
PMID: 34673335
PMC: 8519814.
DOI: 10.1016/j.intimp.2021.108232.
Logistics management provides greater efficiency, governance and compliance.
Ferrara F, Santilli P, Vitiello A, Forte G, DAiuto V
Int J Clin Pharm. 2021; 43(5):1431-1435.
PMID: 34121155
PMC: 8200280.
DOI: 10.1007/s11096-021-01283-6.
